Nature Communications (Jul 2024)

ER calcium depletion as a key driver for impaired ER-to-mitochondria calcium transfer and mitochondrial dysfunction in Wolfram syndrome

  • Mailis Liiv,
  • Annika Vaarmann,
  • Dzhamilja Safiulina,
  • Vinay Choubey,
  • Ruby Gupta,
  • Malle Kuum,
  • Lucia Janickova,
  • Zuzana Hodurova,
  • Michal Cagalinec,
  • Akbar Zeb,
  • Miriam A. Hickey,
  • Yi-Long Huang,
  • Nana Gogichaishvili,
  • Merle Mandel,
  • Mario Plaas,
  • Eero Vasar,
  • Jens Loncke,
  • Tim Vervliet,
  • Ting-Fen Tsai,
  • Geert Bultynck,
  • Vladimir Veksler,
  • Allen Kaasik

DOI
https://doi.org/10.1038/s41467-024-50502-x
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Wolfram syndrome is a rare genetic disease caused by mutations in the WFS1 or CISD2 gene. A primary defect in Wolfram syndrome involves poor ER Ca2+ handling, but how this disturbance leads to the disease is not known. The current study, performed in primary neurons, the most affected and disease-relevant cells, involving both Wolfram syndrome genes, explains how the disturbed ER Ca2+ handling compromises mitochondrial function and affects neuronal health. Loss of ER Ca2+ content and impaired ER-mitochondrial contact sites in the WFS1- or CISD2-deficient neurons is associated with lower IP3R-mediated Ca2+ transfer from ER to mitochondria and decreased mitochondrial Ca2+ uptake. In turn, reduced mitochondrial Ca2+ content inhibits mitochondrial ATP production leading to an increased NADH/NAD+ ratio. The resulting bioenergetic deficit and reductive stress compromise the health of the neurons. Our work also identifies pharmacological targets and compounds that restore Ca2+ homeostasis, enhance mitochondrial function and improve neuronal health.